FUNCTIONAL GENOMICS IN NORMAL INDIVIDUALS: Fronto-cortical Gene Expression
Profile as a Phenotype Impacted by Functional Genetic Polymorphism
Carlo Colantuoni, National Institute of Mental Health, Bethesda, MD
We have
conducted a hypothesis-driven genomics investigation of mRNA expression profiles
in postmortem human brain. Expression profiles were treated as a molecular
phenotype dependent on functional genetic polymorphisms. In a recent study, we
have demonstrated the functional impact of a single nucleotide polymorphism (SNP)
in the catechol-O-methyl transferase (COMT) gene on frontal cortical brain
function and working memory (Egan et al. PNAS 2001). The Val/Met amino acid
substitution in the COMT protein which results from this SNP causes a 4-fold
change in the enzyme’s dopamine metabolizing activity and may also increase risk
for schizophrenia. In the present study, frontal cortical mRNA expression
profiles were measured in two distinct cohorts of 24 normal individuals
segregated by COMT genotype. cDNA microarrays from the National Institute of
Aging in Baltimore were used to assess the expression of thousands of genes in
each postmortem frontal cortex sample. PCR assays were used to determine COMT
genotype in blood or cerebellar tissue from each subject. In addition to the
largest individual gene expression changes, we have focused on the detection of
more subtle expression changes occurring in groups of functionally related genes
that are consistently differentially expressed across COMT genotype. The use of
functional genetic data in combination with both clinical and basic
investigation of functional SNPs provides a link to hypothesis-driven
experimentation in gene expression analysis, and a method to elucidate the
impact of normal genetic variation on gene expression in the brain. We plan to
investigate the Stanley tissue collection in a similar fashion, by analyzing
gene expression patterns across several functional genetic polymorphisms.